Nail Psoriasis Clinical Trial
Official title:
Observational Study on Quality of Life and Ultrasonographic Assessment of Nail Psoriasis After Treatment With Apremilast (JUST Study)
Prospective open label non-randomized study, using Apremilast according to the manufacturer's Summary of Product Characteristics for 52 weeks, in patients with moderate to severe plaque psoriasis and nail psoriasis The study will be carried out in two hospital centers with experience in the management of patients with psoriasis and in the use of ultrasound of the nail apparatus. Visits and ultrasound would be performed by prescribing doctors themselves in their outpatient offices. Prior to the start of the study, the two doctors of each center will conduct a study to see the intraobserver and interobserver agreement on the ecographic parameters. The medication would be dispensed and controlled in the centers themselves and self-administered by patients at home. Each visit includes a ultrasound assessment of a target nail and measures of different scales: NAPSI, NAPPA.
Primary objective:
- Determine the percentage of patients with at least a 20% improvement over the baseline
visit of the NAPPA-PBI scale in weeks 4, 16, 24, 38 and 52.
Secondary objectives:
- Determine the percentage of improvement with respect to the baseline visit of the NAPPA
QoL and CLIN scale in weeks 4, 16, 24, 38 and 52
- Determine the percentage of patients, regarding baseline visit, who reach a NAPSI 50 and
changes in the NAPSI scale, in weeks 4, 16, 24, 38 and 52
- Determine the percentage of improvement or change of the nail ultrasound variables with
respect to the baseline visit in weeks 4, 16, 24, 38 and 52
- Explore the possible correlation between clinical (NAPSI / NAPPA-Clin) and ultrasound
variables before and after treatment
- Determine the percentage of patients with sonographic signs of enthesopathy of the
distal interphalangeal joint before and after treatment
- Determine differences in clinical and sonographic parameters before treatment in good
responders (NAPSI 50) compared to non-responders
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03209388 -
Study of the Efficacy and Safety of Topical P-3073 in the Treatment of Mild to Moderate Psoriatic Fingernail/s
|
Phase 3 | |
| Completed |
NCT00999687 -
Evaluation of the Efficacy and Safety of Indigo Naturalis Oil Extract on Psoriatic Nails
|
Phase 2/Phase 3 | |
| Completed |
NCT00581100 -
Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis
|
Phase 4 | |
| Completed |
NCT04580537 -
Assessing the Efficacy of Image-guided Laser-assisted Enstilar® Delivery for Treatment of Psoriatic Nails
|
Phase 2 | |
| Not yet recruiting |
NCT03263624 -
Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease
|
Phase 4 | |
| Completed |
NCT02606760 -
Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Nails Affected by Psoriasis
|
Phase 3 | |
| Completed |
NCT04227288 -
A Study Evaluating the Efficacy and Tolerability of Enstilar Foam in Patients With Nail Psoriasis
|
Phase 4 | |
| Withdrawn |
NCT03079973 -
Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s
|
Phase 3 | |
| Completed |
NCT04380597 -
Observational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of Life
|
||
| Completed |
NCT03991936 -
Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail Psoriasis
|
Phase 4 | |
| Recruiting |
NCT05124080 -
An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Deucravacitinib for the Treatment of Nail Psoriasis
|
Early Phase 1 | |
| Completed |
NCT03757364 -
Methotrexate in the Treatment of Distal Interphalangeal Joint Extensor Tendon Enthesopathy in Nail Psoriasis
|
||
| Completed |
NCT02016482 -
A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis
|
Phase 3 | |
| Completed |
NCT02168933 -
308nm Excimer Laser for Treatment of Fingernail Psoriasis
|
N/A | |
| Completed |
NCT01445886 -
Comparison of Indigo Naturalis Oil Extract and Calcipotriol Solution in Treating Psoriasis
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT05695833 -
Nd:YAG Laser and Radiofrequency in Treatment of Fingernail Psoriasis
|
N/A | |
| Completed |
NCT02235480 -
Efficacy and Safety of Tazarotene Gel in Nail Psoriasis
|
Phase 2 | |
| Not yet recruiting |
NCT06150794 -
Methotrexate Alone vs Combination With Excimer Light in Nail Psoriasis
|
N/A | |
| Completed |
NCT03946826 -
A Clinical Observation on the Efficacy and Safety of Pulsed Dye Laser (PDL) in the Treatment of Nail Psoriasis
|
N/A | |
| Active, not recruiting |
NCT05072886 -
Study of Efficacy and Safety of Investigational Treatment in Patients With Nail Psoriasis
|
Phase 1 |